# FDA recall D-1538-2022

> **RemedyRepack Inc.** · Class II · drug recall initiated 2022-09-15.

## Product

Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00

## Reason for recall

Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.

## Distribution

Distributed to two direct accounts in PA and AK.

## Key facts

- **Recall number:** D-1538-2022
- **Recalling firm:** RemedyRepack Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-09-15
- **Report date:** 2022-09-21
- **Termination date:** 2022-11-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Indiana, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1538-2022

## Citation

> AI Analytics. FDA recall D-1538-2022. Retrieved 2026-06-12 from https://api.ai-analytics.org/recall/D-1538-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*